• 제목/요약/키워드: poly(d,1-lactide)

검색결과 44건 처리시간 0.025초

역오팔 구조 지지체를 이용한 인간 지방 유래 줄기 세포의 연골 분화 촉진 (Enhanced Chondrogenic Differentiation of Human Adipose-derived Stem Cells with Inverse Opal Scaffolds)

  • 방석호;유태경
    • Korean Chemical Engineering Research
    • /
    • 제51권6호
    • /
    • pp.727-732
    • /
    • 2013
  • 본 연구는 역오팔 지지체를 이용하여 인간지방유래 줄기세포의 연골 분화를 촉진하는 내용을 담고 있다. 비 다공성 구조를 가진 지지체에서 세포를 분화 시도하였을 경우 분화가 잘 촉진되지 않는 것에 비해 200 nm 정도의 균일한 구멍을 가지는 poly(D,L-lactide-co-glycolide)로 구성된 역오팔 지지체는 그 다공성 구조로 인하여 지지체의 내부까지 산소와 유기물의 수송을 가능하게 하여 지지체 내에서 어떤 유전적, 약물적 처리 없이 인간지방유래 줄기세포가 분화가 잘 되게 하는 것을 확인하였다.

응고화 경로가 고분자막 및 함침 약제 형상 변화에 미치는 영향의 분석 (Effect of Coagulating Conditions on the Morphology of Membrane and Drug Being Impregnated)

  • 한명진;남석태;이재훈
    • 폴리머
    • /
    • 제25권2호
    • /
    • pp.151-160
    • /
    • 2001
  • 결정성 약제가 함침된 생분해성 고분자학이 고분자(poly(d,1-lactide)), 약제(progesterone) 및 용매(dimethylformamide)로 이루어진 고분자용액을 고형화시켜 제조되었다. 용매에 약제 및 고분자를 용해시켜 준비된 제막용액을 유리판 위에 도포한 후, 이로부터 용매를 증발시켜 고형화시키거나, 또는 고분자 및 함침 약제 모두에 비용매로 작용하는 물과 용액 필름에 존재하는 용매를 교환시켜 용액 필름이 응고되도록 하였다. 제조된 고분자막들은 용액 필름의 응고화 경로에 따라 뚜렷하게 다른 형상을 보여주었다. 진공 상태에서 용매의 증발을 통해 응고화되었을 때, 함침 약제인 프로제스테론은 구의 형상을 보여주며 고형화된 고분자 구조에 둘러싸여 막의 내부에 균일하게 분포되었다. 이에 비해, 비용매인 물에 침지시켜 용매와 비용매의 급속한 확산에 의해 응고화시키거나, 대기에 방치시켜 대기에 존재하는 수증기의 흡수에 의해 고분자 희박 지역의 핵 형성을 통한 용액 필름의 액체-액체 상분리를 유도하며 응고화시킨 경우, 함침된 약제는 고분자막 내부에 편상의 결정 구조를 지니며 막 내부에 불균일하게 분포되었다.

  • PDF

CELLULAR RESPONSES ON ANODIZED TITANIUM DISCS COATED WITH $1{\alpha}$,25-DIHYDROXYVITAMIN D3 INCORPORATED POLY (D,L-LACTIDE-CO-GLYCOLIDE) (PLGA) NANOPARTICLES

  • Cho, Young-Jin;Heo, Seong-Joo;Koak, Jai-Young;Kim, Seong-Kyun;Lee, Joo-Hee
    • 대한치과보철학회지
    • /
    • 제46권6호
    • /
    • pp.620-627
    • /
    • 2008
  • STATEMENT OF PROBLEM: A biochemical approach for surface modification has offered an alternative for physicochemical and morphological methods to obtain desirable bone-implant interfaces. PURPOSE: The purpose of the present study was to investigate cell responses to poly (D,L-lactide-co-glycolide) (PLGA)/$1{\alpha}$,25-(OH)$_2D_3$ coating with reference to cellular proliferation and differentiation in vitro. MATERIAL AND METHODS: 96 titanium discs were fabricated and divided into four groups. Group 1 was anodized under 300 V as control. Group 2, 3 and 4 were anodized then coated with 3 ml PLGA/$1{\alpha}$,25-(OH)$_2D_3$ solutions. Amount of the solutions were 2 ul, 20 ul and 200ul respectively. The osteoblast-like Human Osteogenic Sarcoma (HOS) cells were seeded and cultured for 1, 3 and 7 days. MTSbased cell proliferation assay and ALPase activity test were carried out. RESULTS: PLGA nanoparticles were observed as fine, smooth and round and HOS cells attached to the anodized surfaces through strand-like and sheet-like filopodia. After 3 days of culture, the dendritic filopodia were exaggerated and sheet-like cytoplasmic projections covered the coated titanium surfaces. After 3 days of culture, all of the groups showed increased cellular proliferation and the lowest proliferation rate was measured on group 2. Higher amount of incorporated $1{\alpha}$,25-(OH)$_2D_3$ (Group 3 and 4) improved cellular proliferation but the differences were not significant statistically (P > .05). But they increased the rate of ALP activities than the control group at day 3 (P < .05). CONCLUSION: Biodegradable PLGA nanoparticles incorporated with vitamin D metabolite positively affected proliferation and differentiation of cells on the anodized titanium surface.

ePTFE 인공혈관에 대한 파클리탁셀의 코팅 및 방출거동 (Paclitaxel Coating on ePTFE Artificial Graft and the Release Behavior)

  • 임순용;김철주;김은진;권오경;권오형
    • 폴리머
    • /
    • 제36권3호
    • /
    • pp.326-331
    • /
    • 2012
  • 본 연구에서는 혈액투석 시 필요한 혈관접근통로로 활용되는 expanded poly(tetrafluoro ethylene)(ePTFE) 인공혈관을 표면 개질하였다. 생분해성 합성고분자인 poly(D,L-lactide-$co$-glycolide)(PLGA)와 함께 항암제로서 뿐만아니라 항증식제제로서 널리 쓰이고 있는 파클리탁셀을 인공혈관 표면에 코팅함으로써 PLGA가 생분해됨에 따라 파클리탁셀을 서방할 수 있도록 고안하였다. 인공혈관의 다공구조 특성을 유지하면서 인공혈관 표면에 1.96 mg/$cm^2$의 PLGA가 코팅되었음을 ATR-FTIR을 통해 확인하였다. 또한 0.263 mg/$cm^2$의 파클리탁셀이 인공혈관에 코팅되었음을 HPLC로 확인하였다. PLGA를 코팅함으로써 인공혈관의 모듈러스는 감소하였으나 인장강도는 향상되었다. 약물방출 실험 결과 PLGA의 생분해거동에 동반하여 코팅된 파클리탁셀의 약 35%가 28일 동안 지속적으로 방출되었다. 이러한 지속적인 파클리탁셀의 방출은 장기간에 걸쳐 신내막 과형성증을 억제하여 혈관의 개존율을 향상시킬 것으로 기대된다.

Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-

  • Das, Jayeeta;Samadder, Asmita;Das, Sreemanti;Paul, Avijit;Khuda-Bukhsh, Anisur Rahman
    • 대한약침학회지
    • /
    • 제19권1호
    • /
    • pp.37-44
    • /
    • 2016
  • Objectives: This study examined the relative efficacies of a derivative of betulinic acid (dBA) and its poly (lactide-co-glycolide) (PLGA) nano-encapsulated form in A549 lung cancer cells in vivo and in co-mutagen [sodium arsenite (SA) + benzo[a]pyrene (BaP)]-induced lung cancer in mice in vivo. Methods: dBA was loaded with PLGA nanoparticles by using the standard solvent displacement method. The sizes and morphologies of nano-dBA (NdBA) were determined by using transmission electron microscopy (TEM), and their intracellular localization was verified by using confocal microscopy. The binding and interaction of NdBA with calf thymus deoxyribonucleic acid (CT-DNA) as a target were analyzed by using conventional circular dichroism (CD) and melting temperature (Tm) profile data. Apoptotic signalling cascades in vitro and in vivo were studied by using an enzyme-linked immunosorbent assay (ELISA); the ability of NdBA to cross the blood-brain barrier (BBB) was also examined. The stage of cell cycle arrest was confirmed by using a fluorescence-activated cell-sorting (FACS) data analysis. Results: The average size of the nanoparticles was ~ 110 nm. Confocal microscopy images confirmed the presence of NdBA in the cellular cytoplasm. The bio-physical properties of dBA and NdBA ascertained from the CD and the Tm profiles revealed that NdBA had greater interaction with the target DNA than dBA did. Both dBA and NdBA arrested cell proliferation at G0/G1, NdBA showing the greater effect. NdBA also induced a greater degree of cytotoxicity in A549 cells, but it had an insignificant cytotoxic effect in normal L6 cells. The results of flow cytometric, cytogenetial and histopathological studies in mice revealed that NdBA caused less nuclear condensation and DNA damage than dBA did. TEM images showed the presence of NdBA in brain samples of NdBA fed mice, indicating its ability to cross the BBB. Conclusion: Thus, compared to dBA, NdBA appears to have greater chemoprotective potential against lung cancer.

Synthesis and pH-Dependent Micellization of a Novel Block Copolymer Containing s- Triazine Linkage

  • Pal Ravindra R.;Lee Doo Sung
    • Macromolecular Research
    • /
    • 제13권5호
    • /
    • pp.373-384
    • /
    • 2005
  • Novel pH-sensitive moieties containing an s-triazine ring were synthesized with sulfonamide and secondary amino groups. The synthesized pH-sensitive moieties were used for the synthesis of a pH-sensitive amphiphilic ABA triblock copolymer. The pH-sensitive triblock copolymer was composed of diblock copolymers, methoxy poly(ethylene glycol)-poly ($\varepsilon$-caprolactone-co-D,L-lactide) (MPEG-PCLA), and pH-sensitive moiety. These copolymers could be dissolved molecularly in both acidic and basic aqueous media at room temperature due to secondary amino and sulfonamide groups. The synthesized s-triazine rings containing pH-sensitive compounds were characterized by ${^1}H-NMR,\;{^13}C-NMR$, and LC/MSD spectral data. The synthesized diblock and triblock copolymers were also characterized by ${^1}H-NMR$ and GPC analyses. The critical micelle concentrations at various pH conditions were determined by fluorescence technique using pyrene as a probe. Furthermore, the micellization and demicellization study of the triblock copolymer was done with pH-sensitive groups. The sensitivity towards pH change was further established by acid-base titration.

Characterization of the rhGH released from rhGH-loaded PLGA microspheres

  • Jo, Yeong-Woo;Lee, Ghun-Il;Park, Yong-Man;Yang, Hi-Chang;Kim, Mi-Ryang;Lee, Sung-Hee;Kwon, Jong-Won;Kim, Won-Bae;Choi, Eung-Chil
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.417.1-417.1
    • /
    • 2002
  • The in vitro release of rhGH from PLGA microspheres was characterized. rhGH-loaded PLGA microspheres were prepared with 50:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers using a double emulsion process. To simulate rhGH release under physiological conditions. the microspheres were suspended in a physiological buller at 37$^{\circ}C$. Quantification of the rhGH released and its molecular form analysis were carried out using SE-HPLC. (omitted)

  • PDF

Effects of Sustained-Release Formulation of Recombinant Human Growth Hormone on Body weight. Bone growth and Organs in Hypophysectomized Rats

  • Jo, Yeong-Woo;Park, Yong-Man;Lee, Ghun-Il;Park, Yong-Man;Yang, Hi-Chang;Kim, Mi-Ryang;Lee, Sung-Hee;Kwon, Jong-Won;Kim, Won-Bae
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.417.2-418
    • /
    • 2002
  • The rhGH-loaded PLGA microsphere formulation was prepared using a double emulsion process from hydrophilic 0:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers. To investigate the sustained efficacy of this formulation, ts pharmacodynamic characteristics were analyzed. It showed particle size of ca 53.1 $\mu\textrm{m}$ with high drug ncorporation efficiency and it was sucutaneously administrated to hypophysectomized rats and whole body rowth responses of this formulation were compared to those of the different dosing patterns of rhGH. (omitted)

  • PDF

In vivo Characterization of Sustained-Release Formulation of Recombinant Human Growth Hormone in Immunosuppressed Rats and Dogs

  • Jo, Yeong-Woo;Park, Yong-Man;Lee, Ghun-Il;Yang, Hi-Chang;Kim, Mi-Ryang;Lee, Sung-Hee;Kwon, Jong-Won;Kim, Won-Bae;Choi, Eung-Chil
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.424.2-424.2
    • /
    • 2002
  • The in vivo release characteristics of rhGH-loaded PLGA microsphere prepared using a double emulsion process from hydrophilic 50:50 poly(D.L-lactide-co-glycolide) (PLGA) polymers were analyzed. This formulation showed particle size of ca 53.1$\mu\textrm{m}$ with high drug incorporation efficiency. To investigate in vivo release kinetics without the interference of formation of antibodies to rhGH in the experimental animals, the animals were immunosuppressed by treatment with Cyclosporin. (omitted)

  • PDF

Preparation and Evaluation of Chrysin Encapsulated in PLGA-PEG Nanoparticles in the T47-D Breast Cancer Cell Line

  • Mohammadinejad, Sina;Akbarzadeh, Abolfazl;Rahmati-Yamchi, Mohammad;Hatam, Saeid;Kachalaki, Saeed;Zohreh, Sanaat;Zarghami, Nosratollah
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권9호
    • /
    • pp.3753-3758
    • /
    • 2015
  • Background: Polymeric nanoparticles are attractive materials that have been widely used in medicine for drug delivery, with therapeutic applications. In our study, polymeric nanoparticles and the anticancer drug, chrysin, were encapsulated into poly (D, L-lactic-co-glycolic acid) poly (ethylene glycol) (PLGA-PEG) nanoparticles for local treatment. Materials and Methods: PLGA: PEG triblock copolymers were synthesized by ring-opening polymerization of D, L-lactide and glycolide as an initiator. The bulk properties of these copolymers were characterized using 1H nuclear magnetic resonance spectroscopy and Fourier transform infrared spectroscopy. In addition, the resulting particles were characterized by scanning electron microscopy. Results: The chrysin encapsulation efficiency achieved for polymeric nanoparticles was 70% control of release kinetics. The cytotoxicity of different concentration of pure chrysin and chrysin loaded in PLGA-PEG ($5-640{\mu}M$) on T47-D breast cancer cell line was analyzed by MTT-assay. Conclusions: There is potential for use of these nanoparticles for biomedical applications. Future work should include in vivo investigation of the targeting capability and effectiveness of these nanoparticles in the treatment of breast cancer.